Todd Joron, Intrinsic Imaging's President and COO, to Speak at Imaging in Clinical Trials, March 29–30 in Philadelphia

March 1, 2016 — Todd Joron, President and COO of Intrinsic Imaging, an FDA audited, ISO 9001:2008 and ISO 13485:2003 certified, GAMP® 5 medical imaging core lab specializing in providing services for Phase I-IV clinical trials, will be presenting at the upcoming Imaging in Clinical Trials event on March 29–30, 2016 at the Wyndham Philadelphia Historic District. Mr. Joron, a long-standing advocate for improving data quality in clinical trials, has been invited to present a session on "Medical Imaging — Advantages of an ISO Certified Quality Management System." This session will review the advantages of having an ISO 9001, ISO 13485 and ISO 22301 certified quality management system designed specifically for managing all aspects of imaging conducted during clinical and medical device trials. Mr. Joron will join other invited speakers from Eisai, Gilead, Merrimack Pharmaceuticals, Merck and Shire to share real world advances in imaging techniques and measurements.

Please join Todd Joron and Amy Zastawney, VP of Business Development on March 29–30 to learn how Intrinsic Imaging's ISO Certified Quality Management System can benefit your next clinical trial.